特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
521463

脳卒中の診断と治療 - 世界市場の将来展望(2017-2026)

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 188 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.89円
脳卒中の診断と治療 - 世界市場の将来展望(2017-2026)
出版日: 2018年08月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 188 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳卒中の診断と治療市場は2017年に238億4,939万米ドルとなりました。今後は8.5%のCAGRで拡大し、2026年には496億9,868万米ドルに達すると予測されています。

当レポートでは、脳卒中の診断と治療の世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • アプリケーション分析
  • 新興市場
  • 今後の市場のシナリオ

第4章 ファイブフォース分析

  • サプライヤーの交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入の脅威
  • 業界内での競争

第5章 脳卒中の診断と治療市場:種類別

  • イントロダクション
  • 診断
    • MRI
    • CTスキャン
    • 心電図
    • 頸動脈超音波
    • 脳血管造影
    • その他
  • 治療法
    • 組織プラスミノーゲン活性化因子
    • 抗血小板薬療法
    • 降圧剤療法
    • 抗凝固療法

第6章 脳卒中の診断と治療市場:用途別

  • イントロダクション
  • 出血性
  • 虚血性

第7章 脳卒中の診断と治療市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第8章 市場の主な動向

  • 買収と合併
  • 合意、パートナーシップ、提携、合弁事業
  • 新製品の発売と拡大戦略
  • その他の活動

第9章 企業プロファイル

  • Siemens AG
  • GE Healthcare
  • Medtronic plc
  • Bayer AG
  • Abbott Laboratories
  • Cordis Corporation
  • Boston Scientific Corporation
  • Genentech, Inc.
  • Koninklijke Philips N.V.
  • Stryker Corporation
  • Merck & Co., Inc
  • B. Braun Melsungen AG
  • Teleflex Inc.
  • Cardinal Health
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb.
  • Boehringer Ingelheim
  • Johnson & Johnson
  • Daiichi Sankyo
図表

List of Tables

  • Table 1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Region (2016-2026) ($MN)
  • Table 2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 17 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 18 North America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 19 North America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 20 North America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 21 North America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 22 North America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 23 North America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 24 North America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 25 North America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 26 North America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 27 North America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 28 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 29 North America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 30 North America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 31 North America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 32 North America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 33 North America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 34 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 35 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 36 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 37 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 38 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 39 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 40 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 41 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 42 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 43 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 44 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 45 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 46 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 47 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 48 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 49 Europe Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 65 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 66 South America Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 67 South America Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 68 South America Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 69 South America Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 70 South America Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 71 South America Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 72 South America Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 73 South America Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 74 South America Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 75 South America Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 76 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 77 South America Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 78 South America Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 79 South America Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 80 South America Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 81 South America Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
  • Table 82 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Type (2016-2026) ($MN)
  • Table 83 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2016-2026) ($MN)
  • Table 84 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2016-2026) ($MN)
  • Table 85 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan) (2016-2026) ($MN)
  • Table 86 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2016-2026) ($MN)
  • Table 87 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2016-2026) ($MN)
  • Table 88 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2016-2026) ($MN)
  • Table 89 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Others (2016-2026) ($MN)
  • Table 90 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics (2016-2026) ($MN)
  • Table 91 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2016-2026) ($MN)
  • Table 92 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet (2016-2026) ($MN)
  • Table 93 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive (2016-2026) ($MN)
  • Table 94 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant (2016-2026) ($MN)
  • Table 95 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Application (2016-2026) ($MN)
  • Table 96 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
  • Table 97 Middle East & Africa Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke (2016-2026) ($MN)
目次

According to Stratistics MRC, the Global Stroke Diagnostics and Therapeutics market is accounted for $23,849.39 Million in 2017 and is expected to reach $49,698.68 Million by 2026 growing at a CAGR of 8.5% during the forecast period. Factors such as technological advancement, growing aging population, and people suffering from diabetes are favouring the market. On the other hand, increasing health expenditure, hypertension and also increasing tobacco users are also fuelling the market. However factors such as unfavourable reimbursement scenario and high cost of treatments are hampering the market growth. Stroke is referred to brain attack occurs when there is a holdup in the supply of blood to the brain which leads brain cells to die.

Depending upon Application, Haemorrhagic Stroke is caused on account of the arteries in the brain either leaking blood or bursting open. When it happens, blood collects in the brain tissue. This is toxic for the brain tissue causing the cells in that area to weaken and die. It is one among the cause of death and a leading cause of serious, long-term disability across the world.

By Geography, stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in and expected to remain top among other regions in the forecast period due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the key players diagnostics and therapeutics market include are Siemens AG, GE Healthcare, Medtronic plc, Bayer AG, Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation, Genentech, Inc., Koninklijke Philips N.V., Stryker Corporation, Merck & Co., Inc, B. Braun Melsungen AG, Teleflex Inc., Cardinal Health, Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Bristol-Myers Squibb., Boehringer Ingelheim, Johnson & Johnson and Daiichi Sankyo.

Types Covered:

  • Diagnostics
  • Therapeutics

Applications Covered:

  • Haemorrhagic Stroke
  • Ischemic Stroke

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Stroke Diagnostics and Therapeutics Market, By Type

  • 5.1 Introduction
  • 5.2 Diagnostics
    • 5.2.1 Magnetic Resonance Imaging (MRI)
    • 5.2.2 Computed Tomography Scan (CT scan)
    • 5.2.3 Electrocardiography
    • 5.2.4 Carotid Ultrasound
    • 5.2.5 Cerebral Angiography
    • 5.2.6 Other Diagnostics
  • 5.3 Therapeutics
    • 5.3.1 Tissue Plasminogen Activator
    • 5.3.2 Antiplatelet
    • 5.3.3 Antihypertensive
    • 5.3.4 Anticoagulant

6 Global Stroke Diagnostics and Therapeutics Market, By Application

  • 6.1 Introduction
  • 6.2 Haemorrhagic Stroke
  • 6.3 Ischemic Stroke

7 Global Stroke Diagnostics and Therapeutics Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Acquisitions & Mergers
  • 8.2 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.3 Product Launch & Expansions
  • 8.4 Other Activities

9 Company Profiling

  • 9.1 Siemens AG
  • 9.2 GE Healthcare
  • 9.3 Medtronic plc
  • 9.4 Bayer AG
  • 9.5 Abbott Laboratories
  • 9.6 Cordis Corporation
  • 9.7 Boston Scientific Corporation
  • 9.8 Genentech, Inc.
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Stryker Corporation
  • 9.11 Merck & Co., Inc
  • 9.12 B. Braun Melsungen AG
  • 9.13 Teleflex Inc.
  • 9.14 Cardinal Health
  • 9.15 Merck Sharp & Dohme Corp.
  • 9.16 GlaxoSmithKline plc
  • 9.17 Bristol-Myers Squibb.
  • 9.18 Boehringer Ingelheim
  • 9.19 Johnson & Johnson
  • 9.20 Daiichi Sankyo
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.